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Abstract The Chk1 protein kinase plays a critical role in a
DNA damage checkpoint pathway conserved between fission
yeast and animals. We have developed a quantitative assay for
Chk1 activity, using a peptide derived from a region of Xenopus
Cdc25C containing Ser-287, a known target of Chk1. Variants
of this peptide were used to determine the residues involved in
substrate recognition by Chk1, revealing the phosphorylation
motif x-X-L-X-X-(S/T)*, where * indicates the phosphorylated
residue, x is a hydrophobic residue (Ms IsLsV), L is a basic
residue (RsK) and X is any amino acid. This motif suggests
that Chk1 is a member of a group of stress-response protein
kinases which phosphorylate target proteins with related
specificities.
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1. Introduction
Eukaryotic cells possess checkpoint mechanisms which en-
sure that cell division is restrained in the presence of damaged
or unreplicated DNA [1,2]. The Chk1 protein kinase is an
essential component of the DNA damage checkpoint pathway
conserved from yeast to animals that regulates entry into mi-
tosis [3^5]. Chk1 phosphorylates the Cdc25 protein phospha-
tase, promoting the binding of a 14-3-3 protein to Cdc25 [6,7]
and preventing nuclear translocation of Cdc25 [8^10]. Cdc25
is thus unable to activate the protein kinase Cdc2/cyclin B and
the cell cycle is arrested prior to mitosis.
Chk1 may also execute its function through phosphoryla-
tion of other substrates. In vitro, Chk1 can phosphorylate
Schizosaccharomyces pombe Wee1, the protein kinase that
maintains inhibitory phosphorylation of Cdc2 [11]. In Saccha-
romyces cerevisiae, Chk1 phosphorylates Pds1, stabilising
Pds1 and preventing the onset of anaphase [12]. However,
the phosphorylation sites on these proteins have not been
identi¢ed. It is also likely that other substrates remain to be
discovered. In order to predict sites of phosphorylation on
known substrates and to identify novel candidate substrates
for a protein kinase, it is useful to determine minimal se-
quence requirements for recognition. The sequence speci¢city
of Chk1 has not been reported, but a comparison of the
sequences surrounding the known Chk1 phosphorylation sites
in the human, Xenopus laevis and S. pombe isoforms of Cdc25
reveals conserved basic and hydrophobic residues N-terminal
to the target serine, suggesting that these residues may be
important for recognition by the kinase (Fig. 1). Here, we
report the substrate speci¢city of human Chk1 determined
using peptides derived from Cdc25C as in vitro substrates.
We de¢ne a recognition motif that is present in other potential
Chk1 substrates. This motif suggests that Chk1 is a member
of a group of related kinases with similar substrate speci¢cities
that respond to di¡erent cellular stresses.
2. Materials and methods
2.1. Expression and puri¢cation of GST-hChk1
A human Chk1 cDNA [5] was sub-cloned as a fusion product with
the glutathione S-transferase (GST) gene into the pFastBac1 vector,
and recombinant baculoviruses were produced using the Bac-to-Bac
system (Gibco). Sf21 insect cells in suspension culture were infected
with GST-hChk1 baculoviruses and incubated at 27‡C for 96 h. The
following steps were carried out at 4‡C: cells were harvested by cen-
trifugation, the cell pellet was resuspended in lysis bu¡er (50 mM
Tris^HCl, pH 8.5, 10 mM dithiothreitol (DTT), 1% (v/v) NP-40, 1
Wg/ml each of leupeptin and aprotinin, 1 mM each of phenylmethyl-
sulphonyl £uoride, pepstatin A, chymostatin and benzamidine), and
sonicated four times for 10 s. The sonicate was centrifuged at
14 000Ug for 10 min, and the supernatant mixed with 1 ml gluta-
thione-Sepharose beads (Pharmacia) for 60 min. After washing with
50 mM Tris^HCl, pH 8.5, 150 mM NaCl, 5 mM DTT, 1%(w/v) NP-
40, GST-hChk1 protein was eluted from the beads by successive in-
cubations with 20 mM HEPES-KOH, pH 7.5, 50 mM reduced gluta-
thione. Eluates containing GST-hChk1 protein (as judged by SDS-
PAGE) were pooled, dialysed against 10 mM HEPES-KOH, pH 7.5,
1 mM DTT, aliquoted, snap-frozen, and stored at 370‡C.
2.2. Synthesis of peptides
The Xenopus Cdc25 ‘SPS’, ‘APS’, ‘SPA’ and ‘human Cdc25C’ pep-
tides were synthesised and puri¢ed by Dr G. Bloomberg, Department
of Biochemistry, University of Bristol, UK. All other peptides were
synthesised on a 1.0 Wmol scale as Cleaved PepSets (Chiron Technol-
ogies, Vic., Australia), dissolved in dimethylsulphoxide (DMSO), and
stored at 370‡C.
2.3. Phosphorylation of peptides by GST-hChk1
Peptides at 200 WM (unless stated otherwise) were phosphorylated
in 50 mM HEPES, pH 7.5, 1 mM DTT, 100 WM Q[32P]ATP (approx.
10 kBq/nmol), 10 mM MgCl2 in a 10 Wl reaction volume containing
approximately 60 ng GST-hChk1. Reactions were carried out for 30
min at 37‡C, then stopped by spotting 8 Wl onto 15 mmU15 mm
squares of Whatman P81 phosphocellulose cation-exchange paper.
Squares were washed three times for 5 min in 500 ml 150 mM H3PO4,
rinsed in ethanol, air-dried and Cerenkov counted for 1 min. Reac-
tions were performed in triplicate and the mean rate of phosphoryla-
tion calculated.
2.4. Kinetic experiments
For assays in which Chk1 activity was determined at various pep-
tide concentrations, serial dilutions of peptide were made in 50 mM
HEPES-KOH (pH 7.5), 25% (v/v) DMSO to give a ¢nal concentra-
tion of 5%(v/v) DMSO in the kinase reaction, with the exception of
the experiment shown in Fig. 2, where no DMSO was present. Re-
action velocity and substrate concentration data were ¢tted to a Mi-
chaelis^Menten curve using GraphPad Prism software, which deter-
mined the kinetic constants Vmax and KM.
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3. Results
3.1. A quantitative assay for Chk1 activity
To generate a substrate for in vitro phosphorylation by
Chk1, we synthesised the peptide, RLYRSPSMPEKLDRK,
derived from residues 281^294 of the Xenopus Cdc25C protein
and including the Ser-287 site phosphorylated by Chk1 [7]. A
C-terminal Lys residue was added to promote binding to
phosphocellulose paper. Phosphorylation of this peptide
(hereafter referred to as the ‘SPS peptide’) was catalysed by
human Chk1 expressed as a fusion protein with glutathione-S-
transferase (Fig. 2). In addition to the Ser-287 site, this pep-
tide contains a serine at position 285 (the numbering corre-
sponding to the position in the parent protein), a residue
reported to be phosphorylated by cyclin-dependent kinases
[13]. A peptide containing a Ser-285 to Ala substitution (the
APS peptide) was phosphorylated with similar kinetics to the
SPS peptide (Fig. 2), showing that Ser-285 is not required
for recognition by Chk1 and is not itself a site of phosphor-
ylation. In contrast, a peptide in which Ser-287 was changed
to an alanine residue (the SPA peptide) was not phosphory-
lated, con¢rming the site of phosphorylation as Ser-287. Since
the kinase used in these studies was the human sequence, we
also compared a peptide derived from human Cdc25C which
has three amino acid changes compared to the APS peptide.
The human-derived sequence was a slightly poorer substrate
than the Xenopus-derived APS peptide and the latter was
therefore used as the parent sequence for subsequent studies.
Standard assay conditions were optimised such that the rate
of phosphorylation was close to the Vmax of the enzyme, lin-
ear up to 60 min, and proportional to the amount of Chk1
used (data not shown).
3.2. Chk1 can phosphorylate serine or threonine, but not
tyrosine residues
All of the phospho-acceptor sites for Chk1 identi¢ed thus
far are serine residues. To determine whether threonine or
tyrosine residues can also be phosphorylated by Chk1, variant
APS peptides, in which Ser-287 was substituted for threonine
or tyrosine, were tested in the Chk1 assay. The Thr-287 pep-
tide was phosphorylated by Chk1 at a rate (28.6 pmol/min)
slightly higher than the Ser-287 peptide (26.2 pmol/min), but
the Tyr-287 peptide was not signi¢cantly phosphorylated.
Chk1 is therefore a protein-serine/threonine kinase, but not
a protein-tyrosine kinase.
3.3. Residues at positions 33 and 35 upstream of the target
phosphorylation site are important for substrate
recognition by Chk1
To determine which residues surrounding the phospho-ac-
ceptor site are important for recognition by Chk1, an alanine
scan analysis of the APS peptide was performed. A panel of
12 APS peptide variants, each with one residue substituted for
alanine, were assayed at 200 WM as substrates for Chk1 (Fig.
3A). Under these conditions, the majority of substitutions had
little e¡ect on the rate of phosphorylation of the peptide.
Apart from the Ser-287 site, the only residues whose substi-
tution to alanine signi¢cantly reduced the rate of phosphor-
ylation were Leu-282 and Arg-284, ¢ve and three residues
upstream of the phosphorylation site, respectively. None of
the downstream residues, when substituted for alanine, caused
a large reduction in the rate of phosphorylation by Chk1.
More detailed kinetic experiments varying the concentration
of substrate (Fig. 3B) showed that whereas substitution of
Arg-281 or Met-288 to alanine resulted in an approximately
two-fold reduction in catalytic e⁄ciency (expressed as Vmax/
KM), substitution of Leu-282 or Arg-284 to alanine reduced
the catalytic e⁄ciency by approximately 20-fold.
3.4. Variations in position and identity of residues surrounding
the targeted serine a¡ect the rate of phosphorylation by
Chk1.
To investigate in more detail the contribution of the critical
residues for recognition by Chk1, we designed a peptide,
RLARAASMAAALARK, based on the APS peptide, but
with seven of the non-essential residues substituted by alanine.
This minimal peptide maintained a high rate of phosphoryla-
tion by Chk1 (Fig. 4A). When Leu35 was substituted with
Met or Ile, the rate of phosphorylation increased, but with
Val or Arg, and particularly Ala substitutions, the rate was
decreased. When Arg33 was substituted with Lys, the peptide
was phosphorylated at 80% of the rate of the parent peptide,
whereas substitution to Ala greatly reduced the rate. Peptides
in which Leu5 was substituted or moved relative to the phos-
phorylated serine residue showed a slight increase in the rate
of phosphorylation, the largest being when Leu was moved
from the +5 to the +4 position. However, a peptide in which
Fig. 1. Amino acid sequence alignment of known Chk1 substrates.
Conserved hydrophobic residues are underlined, conserved basic res-
idues are in bold.
Fig. 2. Comparison of the rate of phosphorylation of Cdc25C pep-
tides by Chk1: (S) Xenopus SPS peptide; (R) Xenopus APS pep-
tide; (F) Human Cdc25C peptide; (b) Xenopus SPA peptide.
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all of the downstream residues were substituted by alanine
was phosphorylated at 89% of the rate of the parent peptide,
showing that residues C-terminal to the phospho-acceptor site
do not play a strong role in substrate recognition by Chk1. A
peptide in which the C-terminal Arg and Lys residues were
swapped onto the N-terminal end of the molecule increased
the rate of phosphorylation by 52%, indicating that N-termi-
nal basic residues are positive determinants. More detailed
kinetic experiments were performed on minimal peptide var-
iants in which the positions of the upstream Leu and Arg
residues were altered (Fig. 4B). Whereas movement of
Arg33 to the 34 or 32 positions resulted in 63% and 92%
of the catalytic e⁄ciency being retained, respectively, move-
ment of Leu35 and Arg33 together relative to the phosphory-
lated Ser resulted in the reduction of the Vmax/KM to less than
35% of that of the minimal peptide. Together these data in-
dicate a minimal consensus for recognition by Chk1 as x-X-L-
X-X-(S/T)*, where * indicates the phosphorylated residue, x
is a hydrophobic residue (Ms IsLsV), L is a basic residue
(R/K) and X is any amino acid.
3.5. Serines 104 and 117 of S. pombe Wee1 are putative sites of
phosphorylation by Chk1
S. pombe Wee1 protein kinase is phosphorylated on one or
Fig. 3. E¡ect of substitution of residues in the Xenopus Cdc25C
APS peptide on phosphorylation by Chk1. A: Alanine scan analy-
sis. B: Comparison of phosphorylation kinetics.
Fig. 4. Comparison of minimal peptides as Chk1 substrates. A: Ef-
fect of substituting speci¢c residues (underlined) on rate of phos-
phorylation: (i) APS peptide and minimal parent peptide; (ii) vary-
ing Leu-282; (iii) varying Arg-284; (iv) varying Leu-292; (v)
substitution of residues 288^293 to Ala, and swapping C-terminal
RK onto N-terminus. B: E¡ect of changing the position of up-
stream residues on the kinetics of phosphorylation.
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more serine residues by Chk1 in vitro [11]. Examination of the
contexts of all the serine residues present in S. pombe Wee1
revealed two sites, Ser-104 and Ser-117, which contained a
basic residue at position 33 and a small hydrophobic residue
at position 35. We found that two peptides containing
these serine residues, PVPRRPS104LFDRPNRK and LVSR-
SSS117RLGDSPRK were phosphorylated at rates comparable
to the APS peptide (Fig. 5). Substitution Ser-104 with Ala
completely abolished phosphorylation by Chk1, con¢rming
this residue as the site of phosphorylation. Substitution of
Ser-117 with Ala reduced the rate of phosphorylation by
64%, indicating that this residue is a target for Chk1, although
other residues in this peptide are also phosphorylated by
Chk1.
3.6. Serine 343 of Xenopus Cdc25C is a good in vitro substrate
for Chk1
Chk1 phosphorylates Xenopus Cdc25C on multiple sites,
although only one of these, Ser-287, has been identi¢ed [7].
Inspection of the Xenopus Cdc25C sequence identi¢ed a po-
tential Chk1 phosphorylation site, Ser-343, within the motif
L-X-K-X-X-S*. This residue is located in a region of Cdc25C
highly conserved between the Xenopus and human forms, and
is equivalent to Ser-263 of human Cdc25C, shown to be a
residue targeted by the kinase C-TAK1 [14]. The Xenopus
Cdc25C-derived peptide SLKKTLS343LCDVDIRK was a
good substrate for Chk1, with a phosphorylation rate 56%
that of the APS peptide (Fig. 5). Phosphorylation of the pep-
tide by Chk1 was abolished when Ser-343 was substituted
with Ala, but 92% of the original rate was maintained when
both Thr-341 and Ser-337 were substituted with Ala, con¢rm-
ing Ser-343 as the residue targeted by Chk1 in this peptide.
3.7. Chk1 can phosphorylate peptide substrates of related
protein kinases
The requirement of Chk1 for upstream hydrophobic and
basic residues is similar to that reported for mammalian
AMP-activated protein kinase (AMPK), plant 3-hydroxy-3-
methylglutaryl-CoA reductase kinase (HRK-A), SNF1 from
S. cerevisiae and the Ca2/calmodulin-dependent protein ki-
nase I (CaMKI) [15]. We therefore wished to determine
whether Chk1 could phosphorylate two peptides used as
substrates for these kinases, the ‘SAMS’ peptide,
HMRSAMS79GLHLVKRR, derived from the sequence sur-
rounding Ser-79 of rat liver acetyl-CoA carboxylase [16], and
the ‘AMARA’ peptide, AMARAASAAALARRR, which
contains the minimal consensus sequence [15]. The SAMS
peptide was phosphorylated at a reasonable rate (33%) com-
pared to the APS peptide (Fig. 5). A peptide with a Ser-79 to
Ala substitution was not phosphorylated, con¢rming this res-
idue as the target of Chk1. The AMARA peptide was a better
substrate for Chk1 than the SAMS peptide, being phosphory-
lated at 92% of the rate of the APS peptide.
4. Discussion
We have determined the substrate speci¢city of the check-
point protein kinase Chk1 using a series of synthetic peptides
derived from a known substrate, Cdc25C. We show that the
most important determinants for substrate recognition by
Chk1 are a hydrophobic residue at position 35
(Ms IsLsV) and a basic residue (RsK) at position 33
relative to the phospho-acceptor site, which can be a serine or
threonine residue. These data allow us to de¢ne the minimal
consensus motif for phosphorylation by Chk1 phosphoryla-
tion as x-X-L-X-X-(S/T)*. This motif is consistent with the
primary sequence context of known Chk1 sites in Cdc25 from
di¡erent species (Fig. 1), which all show a conserved basic
residue (Arg) in the33 position, and a small hydrophobic
residue (Leu or Val) in the 35 position. It seems likely there-
fore that the substrate speci¢city of Chk1 homologues from S.
pombe to vertebrates is conserved.
Using these substrate speci¢city data, we have predicted
likely additional sites targeted by Chk1 in Xenopus Cdc25C
and S. pombe Wee1, and we have con¢rmed that peptides
derived from these sites are indeed phosphorylated by Chk1.
Database searches reveal many other proteins containing po-
tential Chk1 phosphorylation sites. One of these, Pds1, is a
protein involved in controlling the timing of anaphase that
has been proposed recently to be a Chk1 substrate in S. cere-
visiae [12]. Examination of the amino acid sequence reveals
that Pds1 contains six sites conforming to the Chk1 motif that
are putative sites of phosphorylation. Of course, the recogni-
tion motif for a protein kinase is only the minimal require-
ment for phosphorylation. Whether or not a protein is a sub-
strate in cells may depend upon interactions with this motif
and localisation to the same sub-cellular compartment as the
kinase.
The Ser-343 site of Xenopus Cdc25C that we have identi¢ed
as a putative target for Chk1 lies within a region of this
phosphatase highly conserved between frogs and humans.
The equivalent residue in human Cdc25C, Ser-263, is phos-
phorylated by C-TAK1 [14]. This kinase also phosphorylates
Ser-216 [14], the major site phosphorylated by Chk1 [5] and
Chk2 [17]. In S. pombe, Cds1 and Chk1 phosphorylate Cdc25
in an identical manner on three serine residues in vitro [18].
Taken together, these results suggest that the three kinases
Chk1, Cds1 and C-TAK1 have very similar phosphorylation
motifs.
The catalytic domains of Chk1, Cds1 and C-TAK1 is most
closely related in sequence to the Ca2/calmodulin-dependent
protein kinase (CaMK) group [19]. Other members of this
Fig. 5. Rate of phosphorylation of peptides predicted to be sub-
strates of Chk1: (i) APS (Xenopus Cdc25C Ser-287) peptide; (ii)
S. pombe Wee1 (Ser-104); (iii) S. pombe Wee1 (Ser-117); (iv) Xeno-
pus Cdc25C (Ser-343); (v) SAMS [16] and AMARA [15] peptides.
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group, AMPK, SNF1 and CaMKI, similarly require N-termi-
nal basic and hydrophobic residues, although they have a
stronger preference for C-terminal hydrophobic residues
than Chk1 [15,20]. Consistent with these related speci¢cities,
Chk1 phosphorylates two peptide substrates designed for
AMPK. How then can the sequence speci¢cities of these
Ser/Thr protein kinases be rationalised, based on their struc-
tures? X-ray crystallographic studies of the catalytic domains
of several protein kinases have identi¢ed residues which form
the ‘speci¢city pockets’ that determine substrate recognition
[21,22]. In the autoinhibited form of CaMKI [23], the active
site of the kinase is occupied by a pseudosubstrate region
(297NFAKSKW*KQAFN308) containing the x-X-L-X-X-(S/
T)*-X-X-X-x motif found in substrates of this kinase [24],
but with a non-phosphorylatable Trp residue in the phos-
pho-acceptor position. There is an electrostatic interaction
between Glu-102 in the catalytic domain and Lys-300 in the
pseudosubstrate. A hydrophobic pocket formed by residues
Phe-104, Ile-210 and Pro-216 accommodates a hydrophobic
residue at position 35 in the pseudosubstrate. Sequence align-
ment shows that these contact-making residues are conserved
in the catalytic domains of kinases which share similar phos-
phorylation motifs. In an analysis of 24 protein- Ser/Thr kin-
ases, we ¢nd that the residue in the position equivalent to
Glu-102 in CaMKI is acidic (either Glu or Asp) in kinases
(including Chk1) which recognise an upstream basic residue in
their substrates. Similarly, all three of the residues Phe-104,
Ile-210 and Pro-216 are retained or conservatively substituted
in those kinases (including Chk1) which require a hydropho-
bic residue at the 35 position. Both the Glu-102 equivalent
residue and the hydrophobic pocket-forming triplet are also
conserved in the kinases C-TAK1, Cds1 and Chk2, further
suggesting that they share with Chk1 the x-X-L-X-X-S/T*
substrate recognition motif.
While this group of protein-serine/threonine kinases have
related catalytic domains with similar substrate speci¢cities,
they have distinct regulatory domains that respond to di¡er-
ent cellular stresses, e.g. ATP depletion (AMPK), glucose
starvation (SNF1), elevated cytoplasmic Ca2 concentration
(CaMKI), DNA damage (Chk1) or DNA replication arrest
(Cds1/Chk2). While it remains to be determined if these ki-
nases have common substrates in vivo, it may be interesting to
examine the possible e¡ects of stresses other than DNA dam-
age or DNA replication arrest on the phosphorylation of
Cdc25 and the timing of mitotic initiation. It may also be
interesting to examine whether Chk1 can phosphorylate
known substrates of these related kinases, which include met-
abolic enzymes and transcription factors [25].
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